3FO9 image
Deposition Date 2008-12-29
Release Date 2009-12-22
Last Version Date 2024-10-30
Entry Detail
PDB ID:
3FO9
Keywords:
Title:
Crystal structure of aldolase antibody 33F12 Fab' in complex with hapten 1,3-diketone
Biological Source:
Source Organism:
Mus musculus (Taxon ID: 10090)
Host Organism:
Method Details:
Experimental Method:
Resolution:
1.90 Å
R-Value Free:
0.24
R-Value Work:
0.21
R-Value Observed:
0.21
Space Group:
P 21 21 21
Macromolecular Entities
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:Immunoglobulin IGG2A - heavy chain
Chain IDs:B (auth: H), D (auth: B)
Chain Length:218
Number of Molecules:2
Biological Source:Mus musculus
Polymer Type:polypeptide(L)
Molecule:Immunoglobulin IGG2A - light chain
Chain IDs:A (auth: L), C (auth: A)
Chain Length:219
Number of Molecules:2
Biological Source:Mus musculus
Ligand Molecules
Primary Citation
Direct observation of an enamine intermediate in amine catalysis
J.Am.Chem.Soc. 131 18206 18207 (2009)
PMID: 19968282 DOI: 10.1021/ja907271a

Abstact

An enamine intermediate is believed to be the central feature of biological catalysts, such as aldolases and small molecule amine organocatalysts. Despite decades of investigation of naturally occurring aldolase enzymes and recent studies on designed aldolase antibodies and organocatalysts, direct structural observation of an enamine intermediate has proven to be rare. Herein, we report the observation of a stable enamine intermediate in the crystal structure of an aldolase antibody 33F12 in complex with a 1,3-diketone derivative. This enamine complex structure provides strong evidence that fewer residues are essential for amine catalysis within the hydrophobic environments of this catalytic antibody than speculated for natural aldolase enzymes and should serve to guide future studies aimed at the rational design of these types of catalysts, as well as organocatalysts. Indeed, enamine catalysis in proteins might be more simplistic than previously imagined.

Legend

Protein

Chemical

Disease

Primary Citation of related structures